Who owns Momenta Pharmaceuticals?

Key details on Momenta Pharmaceuticals (Ticker: MNTA)

Who owns Momenta Pharmaceuticals?

Is MNTA a good stock to own? Find out who bought Momenta Pharmaceuticals, who sold Momenta Pharmaceuticals (MNTA) stock, and who holds a large position in Momenta Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Scopia Management 3.80M $44.80M Dec. 31, 2012
Visium Asset Management 3.62M $64.00M Dec. 31, 2013
BlackRock Fund Advisors 3.27M $39.34M Dec. 31, 2014
Vanguard 3.06M $36.88M Dec. 31, 2014
S.A.C. Capital Advisors 3.03M $35.29M March 31, 2014
FMR 2.92M $33.07M Sept. 30, 2014
Wellington Management Company 2.81M $40.93M Sept. 30, 2012
PRIMECAP Management Company 2.67M $32.15M Dec. 31, 2014
Discovery Capital Management 2.65M $31.93M Dec. 31, 2014
T. Rowe Price Associates 2.59M $31.17M Dec. 31, 2014
North Tide Capital 2.50M $30.10M Dec. 31, 2014
STATE STREET CORPORATION 2.13M $25.60M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 1.55M $18.62M Dec. 31, 2014
Sectoral Asset Management 1.46M $17.57M Dec. 31, 2014
Palo Alto Investors 1.46M $17.52M Dec. 31, 2014
Acadian Asset Management 1.33M $19.40M Sept. 30, 2012
Tocqueville Asset Management 1.32M $15.89M Dec. 31, 2014
Heartland Advisors 1.22M $14.65M Dec. 31, 2014
ALLIANCEBERNSTEIN 1.19M $21.04M Dec. 31, 2013
Millennium Management 1.17M $14.14M Dec. 31, 2014
Deerfield Management Company 1.14M $20.10M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 1.11M $13.39M June 30, 2014
Frontier Capital Management 1.10M $13.00M Dec. 31, 2012

Who sold Momenta Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
OppenheimerFunds June 30, 2011 5.50M $107.07M
Citi March 31, 2011 1.66M $26.30M
OrbiMed Advisors Dec. 31, 2010 2.16M $32.35M
Barclays Dec. 31, 2010 1.70M $25.42M